| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8528136 | Clinical Therapeutics | 2018 | 17 Pages |
Abstract
Application of the knowledge of immune checkpoint inhibitor use in gynecologic cancers will improve care for women with cancers of the female reproductive tract. As more complex and newer immunotherapies evolve, it will be vital to accurately characterize each specific drug class and management thereof.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Tara MD, Kathleen N. MD, MS, Laura L. MD, MS,